Imaging for Response Assessment in Cancer Clinical Trials-Reference-Cited by-同舟云学术

Imaging for Response Assessment in Cancer Clinical Trials

Published:2020-11 Issue:6 Volume:50 Page:488-504
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Sorace Anna G.,Elkassem Asser A.,Galgano Samuel J.,Lapi Suzanne E.,Larimer Benjamin M.,Partridge Savannah C.,Quarles C. Chad,Reeves Kirsten,Napier Tiara S.,Song Patrick N.,Yankeelov Thomas E.,Woodard Stefanie,Smith Andrew D.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference137 articles.

1. Looking back on the millennium in medicine;N Engl J Med,2000

2. . In: BEST (Biomarkers, EndpointS, and other Tools) Resource. edn. Silver Spring (MD); 2016.

3. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework;Clin Pharmacol Ther,2001

4. Imaging biomarker roadmap for cancer studies;O'Connor;Nat Rev Clin Oncol,2017

5. RECIST 1.1-Update and clarification: From the RECIST committee;Schwartz;Eur J Cancer,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose (¹⁸F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness;Veterinary Radiology & Ultrasound;2024-04-24

2. In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla;International Journal of Molecular Sciences;2024-01-31

3. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management;Future Journal of Pharmaceutical Sciences;2024-01-05

4. Glycerol and its derivatives as potential C-3 bio-based building blocks for accessing active pharmaceutical ingredients;Green Chemistry;2024

5. Vbir-Based Assessment of Radiographic-Divergence Agent Attention in Prostate Melanoma Patients;2024